SMMT · Summit Therapeutics Inc.
$12.79
+0.24 (+1.91%)
At close · Jul 29
Market Cap
$10.01B
Shares
797.75M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Manmeet Soni | CFO | $249,127,782 |
| Mahkam Zanganeh | CEO | $246,047,279 |
| Robert Duggan | CEO | $172,376 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Manmeet Soni | CFO | $4,772,489 |
| Mahkam Zanganeh | CEO | $1,161,021 |
| Ankur Dhingra | CFO | $256,280 |
| Robert Duggan | CEO | $158,613 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Manmeet Soni | CFO | $23,613,339 |
| Mahkam Zanganeh | CEO | $20,562,924 |
| Ankur Dhingra | CFO | $621,251 |
| Robert Duggan | CEO | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Ankur Dhingra | CFO | $1,362,850 |
| Mahkam Zanganeh | CEO | $1,242,049 |
| Robert Duggan | CEO | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Mahkam Zanganeh | CEO | $9,639,214 |
| David Powell | Former Chief Scientific Officer | $1,606,698 |
| Jeffrey Maranian | Principal Accounting Officer | $1,044,147 |
| Robert Duggan | CEO | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Michael Donaldson | CFO | $961,418 |
| Ventzislav Stefanov | Board Member | $674,823 |
| Glyn Edwards | CEO | $621,822 |
| Mahkam Zanganeh | CEO | $527,312 |
| David Powell | Former Chief Scientific Officer | $401,124 |
| Robert Duggan | CEO | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Glyn Edwards | CEO | $871,908 |
| Robert Duggan | CEO | — |
Key facts
CIK
1599298
CUSIP
86627T108
13F (30d)
33 filings
33 filers
Visit website
Investor relations